SCHEMBL822346

SCHEMBL822346

CNC(=NC#N)NC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13670700 0.80
SCHEMBL11477580 0.80
SCHEMBL19080498 0.80
SCHEMBL26564689 0.80
SCHEMBL13668063 0.80
SCHEMBL14773217 0.80
SCHEMBL25761105 0.80
SCHEMBL24961919 0.78
SCHEMBL9353816 0.78
SCHEMBL9353813 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116199248-A Method for preparing nano calcium carbonate by recycling carbon dioxide absorbent 中国科学院兰州化学物理研究所 2023-06-02 CN claimed
CN-113797714-A Composite absorbent for capturing, separating and purifying carbon dioxide 中国科学院兰州化学物理研究所 2021-12-17 CN claimed
US-20250145760-A1 EPOXY RESIN COMPOSITIONS COMPRISING DICYANDIAMID CURING AGENT 3M INNOVATIVE PROPERTIES COMPANY 2025-05-08 US disclosed
CN-119072512-A Epoxy resin composition comprising dicyandiamide curing agent 3M创新有限公司 2024-12-03 CN disclosed
EP-4442727-A1 EPOXY RESIN COMPOSITIONS COMPRISING A LEWIS ACID 3M Innovative Properties Company (US) 2024-10-09 EP disclosed
EP-4442746-A1 EPOXY RESIN COMPOSITIONS SUITABLE FOR BONDING TO OILY SURFACE 3M Innovative Properties Company (US) 2024-10-09 EP disclosed
WO-2024129982-A2 CIRCULAR RNA COMPOSITIONS AND METHODS ORNA THERAPEUTICS, INC. (US) 2024-06-20 WO disclosed
US-20230357133-A1 NANOMATERIALS COMPRISING CARBONATES BEAM THERAPEUTICS INC. 2023-11-09 US disclosed
US-20230357133-A1 NANOMATERIALS COMPRISING CARBONATES BEAM THERAPEUTICS INC. 2023-11-09 US disclosed
WO-2023166367-A1 EPOXY RESIN COMPOSITIONS COMPRISING DICYANDIAMID CURING AGENT 3M INNOVATIVE PROPERTIES COMPANY (US) 2023-09-07 WO disclosed
CN-111848494-B Guanidine compounds and uses thereof 伊谬诺米特医疗有限公司 2023-08-01 CN disclosed
US-20130295051-A1 NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT VALO HEALTH, INC. 2013-11-07 US disclosed
CN-101838241-B Production method of cimetidine WUXI KAILI PHARMACEUTICAL CO LTD 2012-11-07 CN disclosed
US-20120029036-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING PYRIDYL CYANOGUANIDINE, PROCESS FOR PREPARING THE SAME AND USE THEREOF TIANJIN MICHELE SCI-TECH DEVELOPMENT CO., LTD. (CN) 2012-02-02 US disclosed
EP-2394649-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING PYRIDYL CYANOGUANIDINES, PREPARATION METHODS AND USES THEREOF Tianjin Hemay Bio-Tech Co., Ltd. (CN) 2011-12-14 EP disclosed
CN-101838241-A Production method of cimetidine WUXI KAILI PHARMACEUTICAL CO LTD 2010-09-22 CN disclosed
US-20080194630-A1 Leukotriene A-4 hydrolase inhibitors; antiinflammatory agents; skin disorders; analgesics; stroke; anticancer agents; antiallergens; rhinitis;cystic fibrosis;sepsis JANSSEN PHARMACEUTICA N.V. (BE) 2008-08-14 US disclosed
EP-1411984-B1 COMBINATION MEDICAMENT FOR TREATMENT OF NEOPLASTIC DISEASES WHICH CONTAINS CYANOGUANIDINE IKK INHIBITORS AND A SECOND ANTI-NEOPLASTIC DRUG LEO PHARMA AS (DK) 2008-05-07 EP disclosed
WO-2005009354-A2 COMPOSITIONS OF A CYCLOOXYGENASE-2 SELECTIVE INHIBITOR AND AN IKK INHIBITOR FOR THE TREATMENT OF ISCHEMIC-MEDIATED CENTRAL NERVOUS SYSTEM DISORDERS OR INJURY PHARMACIA CORPORATION (US) 2005-02-03 WO disclosed
CN-1245854-A Processed timber SUMITOMO CHEMICAL CO (JP) 2000-03-01 CN disclosed